4 completed. 3 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
| Not applicable | 1 | Completed 1 |
Follow Gary E. Stein, Pharm.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia Ceftaroline, Levofloxacin - Pneumonia, Bacterial, Community-acquired | Phase 4 | Completed | Gary E. Stein, Pharm.D. | 12 | 2012-02-01 | 2016-04-12 |
| Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD) Tigecycline - Diarrhea, Clostridium Difficile | Not applicable | Completed | Gary E. Stein, Pharm.D. | 10 | 2011-07-01 | 2018-07-10 |
| Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients Doripenem, doripenem - Febrile Neutropenia | Phase 4 | Completed | Gary E. Stein, Pharm.D. | 12 | 2010-08-01 | 2015-10-14 |
| Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins micafungin, Micafungin, Caspofungin - Candidemia | Phase 4 | Completed | Gary E. Stein, Pharm.D. | 21 | 2008-12-01 | 2024-04-30 |
Candidemia (1) · Diarrhea (1) · Febrile Neutropenia (1) · Neutropenia (1) · Pneumonia (1) · Pneumonia, Bacterial (1)
Caspofungin (1) · Ceftaroline (1) · Doripenem (1) · Levofloxacin (1) · Micafungin (1) · Tigecycline (1)
United States (4)
Gary E Stein, Pharm.D. (2) · Gary Stein, PharmD (2)